Antibiotics


DreamPharm Products:

Lutein|| Milk thistle||Saw palmetto|| Triple B Super Vision||Garlic, Ginger, and Grapeseed Extract|| Ginseng and Ginkgo||Hair Million|| DHEA||Coenzyme Q10|| Sleep Aid herbal formula - natural sleep aid||Herbal Breath - herbs for bad breath problems.|| Weight loss herbal formula||Ginkgo biloba|| Colon cleansing, Laxative||ViaVita Zithromax, azithromycin antibiotics







  • Beta-lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain.
  • Effect of electrical charges and fields on injury and viability of airborne bacteria.
  • Identification of amino acid residues of anthrax protective antigen involved in binding with lethal factor.
  • Preparedness of the Israeli health system for a biologic warfare event.
  • The epidemiologic pyramid of bioterrorism.
  • The probability of severe disease in zoonotic and commensal infections.
  • Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague.
  • Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax.
  • Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax.
  • Cutaneous anthrax of the hand and its reconstruction with a reverse-flow radial forearm flap.
  • The impact of anthrax attacks on the American public.
  • Management of asymptomatic pregnant or lactating women exposed to anthrax.
  • Bioterrorism
  • National preparedness for biological mass casualty event: between the devil and the deep blue sea
  • Hypersensitivity pneumonitis following anthrax vaccination.
  • Anthrax edema toxin requires influx of calcium for inducing cyclic AMP toxicity in target cells.
  • Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus.
  • Cutaneous anthrax: an endemic outbreak in south India.
  • Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition.
  • Gln277 and Phe554 residues are involved in thermal inactivation of protective antigen of Bacillus anthracis.
  • Mapping of antibody responses to the protective antigen of Bacillus anthracis by flow cytometric analysis.
  • GI anthrax: report of one case confirmed with autopsy.
  • Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells.
  • Risk analysis and risk management in an uncertain world.
  • Management of anthrax.
  • Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.
  • Antimicrobial susceptibility of Bacillus anthracis in an endemic area.
  • Delayed treatment with doxycycline has limited effect on anthrax infection in BLK57/B6 mice.
  • Disaster planning and emergency preparedness: lessons learned.
  • Infection and invasion of humans in the Yamal Peninsula
  • Believe it or not--silver still poisons!
  • Delivery of nucleic acid into mammalian cells by anthrax toxin.
  • Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs.
  • Basis for the extraordinary genetic stability of anthrax.
  • Open-market innovation.
  • Prevention of bioterrorism by vaccines
  • Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.
  • First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001.
  • First case of bioterrorism-related inhalational anthrax, Florida, 2001: North Carolina investigation.
  • Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response.
  • Secondary aerosolization of viable Bacillus anthracis spores in a contaminated US Senate Office.
  • Bacillus anthracis aerosolization associated with a contaminated mail sorting machine.
  • abst 152
  • Bioterrorism-related anthrax: international response by the Centers for Disease Control and Prevention.
  • abst 154
  • Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001.
  • Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001.
  • Bioterrorism-related anthrax surveillance, Connecticut, September-December, 2001.
  • abst 159
  • Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins.
  • abst 161
  • Coordinated response to reports of possible anthrax contamination, Idaho, 2001.
  • Laboratory response to anthrax bioterrorism, New York City, 2001.
  • abst 165
  • abst 167
  • abst 169
  • Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-alpha.
  • abst 171
  • abst 173
  • Collaboration between public health and law enforcement: new paradigms and partnerships for bioterrorism planning and response.
  • Identification of Bacillus anthracis by a simple protective antigen-specific mAb dot-ELISA.
  • Bioterrorism: the role of veterinarians in detection and prevention
  • Structural analysis and evidence for dynamic emergence of Bacillus anthracis S-layer networks.
  • The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria.
  • Calcium dependence of the interaction between calmodulin and anthrax edema factor.
  • Anthrax lethal factor represses glucocorticoid and progesterone receptor activity.
  • Australia's notifiable diseases status, 2001: annual report of the National Notifiable Diseases Surveillance System.
  • Characterisation of the immune response to the UK human anthrax vaccine.
  • Genetic diversity in the protective antigen gene of Bacillus anthracis.
  • Increase in efficacy of antibiotic therapy of anthrax under experimental conditions
  • Modern possibilities of bioterrorism diagnosis
  • Genome differences that distinguish Bacillus anthracis from Bacillus cereus and Bacillus thuringiensis.
  • Biosensor for the specific detection of a single viable B. anthracis spore.
  • Increased US prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaign.
  • Infection control practitioners' perceptions and educational needs regarding bioterrorism: Results from a national needs assessment survey.
  • The anthrax team: a novel teaching approach to increase anthrax and bioterrorism awareness.
  • Anthrax and the mail: The making of an educational video for mail workers.
  • Endemic gastrointestinal anthrax in 1960s Lebanon: clinical manifestations and surgical findings.
  • asbt 199
  • Involvement of phospholipase A2 activation in anthrax lethal toxin-induced cytotoxicity.
  • Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge.
  • A fragment of anthrax lethal factor delivers proteins to the cytosol without requiring protective antigen.
  • The history of anthrax.
  • Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
  • Anthrax during pregnancy: case reports and review.
  • Biological weapons preparedness: the role of physicians.
  • Structural studies on the hairpins at the 3' untranslated region of an anthrax toxin gene.
  • Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
  • Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin.
  • Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin.
  • Contribution of determinants, located in Bacillus anthracis chromosomes, in realizing the pathogenic properties of the pathogen
  • Bacillus spores for vaccine delivery.
  • Characterization of dominant-negative forms of anthrax protective antigen.
  • Chemical weapon functional exercise--Cincinnati: observations and lessons learned from a "typical medium-sized" city's response to simulated terrorism utilizing Weapons of Mass Destruction.
  • Bioterrorism web site resources for infectious disease clinicians and epidemiologists.
  • Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody.
  • Experiences with anthrax emergency measures during 2001 and 2002 in the city of Essen
  • U.S. military officer participation in the Centers for Disease Control and Prevention's Epidemic Intelligence Service (1951-2001).
  • Bioterrorism: What? Why? and Who?
  • Endoprotease PACE4 is Ca2+-dependent and temperature-sensitive and can partly rescue the phenotype of a furin-deficient cell strain.
  • abst 222 abst 222
  • abst 224
  • A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates.
  • Clinical evaluation of the Emergency Medical Services (EMS) ambulance dispatch-based syndromic surveillance system, New York City.
  • Syndromic surveillance using automated collection of computerized discharge diagnoses.
  • Horizontal transfer of drug-resistant aminoacyl-transfer-RNA synthetases of anthrax and Gram-positive pathogens.
  • The crystal structure of the proprotein processing proteinase furin explains its stringent specificity.
  • Production and cell surface anchoring of functional fusions between the SLH motifs of the Bacillus anthracis S-layer proteins and the Bacillus subtilis levansucrase.
  • Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants.
  • The host cell chaperone Hsp90 is essential for translocation of the binary Clostridium botulinum C2 toxin into the cytosol.
  • Hypothesis: Ran GTPase-Based Potential Therapeutic Interventions Against Lethal Microbial Infections.
  • Creating a Text Classifier to Detect Radiology Reports Describing Mediastinal Findings Associated with Inhalational Anthrax and Other Disorders.
  • abst 236
  • Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge.
  • Anthrax-protective effects of yeast beta 1,3 glucans.
  • Changes in ciprofloxacin utilization as shown in a large pharmacy claims database: effects of proximity to criminal anthrax exposure in October 2001.
  • Activation of phospholipase C and protein kinase C is required for expression of anthrax lethal toxin cytotoxicity in J774A.1 cells.
  • Bioterrorism and catastrophe response: a quick-reference guide to resources.
  • Organization of a health-system pharmacy team to respond to episodes of terrorism.
  • Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine.
  • abst 244
  • Susceptibility of Bacillus anthracis to eleven antimicrobial agents including novel fluoroquinolones and a ketolide.
  • Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin.
  • Bacillus species proteins involved in spore formation and degradation: from identification in the genome, to sequence analysis, and determination of function and structure.
  • Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens.
  • Pathology and pathogenesis of bioterrorism-related inhalational anthrax.
  • Bioterrorism alleging use of anthrax and interim guidelines for management--United States, 1998.
  • Patient and family physician preferences for care and communication in the eventuality of anthrax terrorism.
  • Efficacy and durability of Bacillus anthracis bacteriophages used against spores.
  • Anthrax toxin: structures, functions and tumour targeting.
  • Production and proteolytic assay of lethal factor from Bacillus anthracis.
  • The metalloproteolytic activity of the anthrax lethal factor is substrate-inhibited.
  • Decontamination by fumigation.
  • Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak.
  • Deletion mutants of protective antigen that inhibit anthrax toxin both in vitro and in vivo.
  • Anxiety-related visits to Ontario physicians following September 11, 2001.
  • Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells.
  • In Process Citation
  • Specific staining of bacilli by means of immuno-indian-ink method and immunofluorescent method.
  • Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin.
  • Adverse reactions to anthrax immunisation in a military field hospital.
  • Expression and purification of the Bacillus anthracis protective antigen domain 4.
  • Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin.
  • Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.
  • Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity.
  • Biological consequences of multiple vaccine and pyridostigmine pretreatment in the guinea pig.
  • Bioterrorism--a public and health threat
  • Rapid recovery and identification of anthrax bacteria from the environment.
  • Facial Cutaneous Anthrax in a Pregnant Woman: a Case Report.
  • Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.
  • Point mutations in anthrax protective antigen that block translocation.
  • Some hygienic problems in the production of meat and bone meal from slaughterhouse offal and animal carcasses.
  • Sporulation of anthrax bacilli
  • The poison center role in biological and chemical terrorism.
  • Bacillus anthracis diversity in Kruger National Park.
  • Extraordinary infections: a focus on bioterrorism.
  • Dehydroepiandrosterone and melatonin prevent Bacillus anthracis lethal toxin-induced TNF production in macrophages.
  • PCR amplification on a microarray of gel-immobilized oligonucleotides: detection of bacterial toxin- and drug-resistant genes and their mutations.
  • Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin.
  • Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis.
  • Global effects of virulence gene regulators in a Bacillus anthracis strain with both virulence plasmids.
  • Expression of anthrax lethal factor gene by osmolyte induction.
  • Monitoring anthrax vaccine safety in US military service members on active duty: surveillance of 1998 hospitalizations in temporal association with anthrax immunization.
  • Mailborne transmission of anthrax: Modeling and implications.
  • Evaluation of the relation between the traditional index on the identification of Bacillus anthracis and its virulence determinant genes
  • Inhalational Anthrax.
  • Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
  • In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody.
  • Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity.
  • Responding to chemical, biological, or nuclear terrorism: the indirect and long-term health effects may present the greatest challenge.
  • Lethal toxin of Bacillus anthracis causes apoptosis of macrophages.
  • Occurrence of anthrax in Kars district, Turkey.
  • Self-reported changes in subjective health and anthrax vaccination as reported by over 900 Persian Gulf War era veterans.
  • Development and application of an analytical method for the determination of squalene in formulations of anthrax vaccine adsorbed.
  • Update: Cutaneous anthrax in a laboratory worker--Texas, 2002.
  • Fatal case of inhalational anthrax mimicking intra-abdominal sepsis.
  • Dealing with the dangers of fear: the role of risk communication.
  • Anthrax in adults and children: a review of 132 cases in Turkey.
  • 2001 anthrax crisis in Washington, D.C.: clinic for persons exposed to contaminated mail.
  • 2001 anthrax crisis in Washington, D.C.: pharmacists' role in screening patients and selecting prophylaxis.
  • A perspective: risk analysis as a tool for reducing the risks of terrorism.
  • Perceptions of state public health officers and state veterinarians regarding risks of bioterrorism in the United States.
  • Anthrax of the gastrointestinal tract.
  • A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium.
  • Asp 187 and Phe 190 residues in lethal factor are required for the expression of anthrax lethal toxin activity.
  • Public health and national security: the critical role of increased federal support.










    DreamPharm offers Hair Million (have you heard?) to help treat hair loss problems. Numerous anecdotal cases have demonstrated that this herbal formula based on traditional Chinese herbs actually improves hair thinning and hair loss, a condition often associated with aging, for a significant fraction of people who take the formula regularly. It is not yet understood how Hair Million can stop hair loss and promote hair growth. No scientific research or placebo controlled clinical analysis has been performed on these herbs. Lack of scientific/clinical research is not uncommon in herbal arena. Nonetheless, there are two merits in this hair restoration herbal formula: Firstly, Hair Million is relatively inexpensive, and secondly, it is made of edible herbs that are known to be safe when consumed in regular quantities. Buy Propecia Online is a clinically tested prescription medication.









    Online Pharmacies|| Buy Cialis || Insurance policies: life insurance, health insurance, home insurance, automobile insurance || Buy Xenical Online || DreamPharm Prescription Medicine Online || Dream Pharmaceuticals Rx: prescription medication and drugs online ||